Search research articles
Contact Us
Filters
Showing results (71-80 of 141) with videos related to
Page
of 15
Sort By:
Personalized Medicine
|
August 14, 2023
Budget impact and transferability of cost-effectiveness of <i>DPYD</i> testing in metastatic breast cancer in three health systems
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, et al.
Lancet (London, England)
|
July 5, 2025
Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply
Timothy L Jackson, Helen Dakin, Xuemin Zhu, et al.
Personalized Medicine
|
September 4, 2023
Cost-effectiveness of extended <i>DPYD</i> testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, et al.
Family Practice
|
June 22, 2006
Cluster randomized trial of a multifaceted primary care decision-support intervention for inherited breast cancer risk
Brenda J Wilson, Nicola Torrance, Jill Mollison, et al.
Genomic Medicine
|
October 17, 2008
Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom
Sarah Wordsworth, James Buchanan, Regina Regan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 13, 2022
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib
Simone Huygens, Heleen Vellekoop, Matthijs Versteegh, et al.
Applied Health Economics and Health Policy
|
April 4, 2022
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 2, 2023
Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
Chi Kin Law, Anne E Cust, Amelia K Smit, et al.
BMC Public Health
|
March 17, 2026
Social impact bonds: opportunities for funding health promotion and disease prevention
Stefánia Plankó, Emily Hulse, Maureen Rutten-van Mölken, et al.
Communications Medicine
|
May 25, 2024
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use
Laurence S J Roope, Liz Morrell, James Buchanan, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 141) with videos related to
Sort By:
Page
of 15
Personalized Medicine
|
August 14, 2023
Budget impact and transferability of cost-effectiveness of <i>DPYD</i> testing in metastatic breast cancer in three health systems
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, et al.
Lancet (London, England)
|
July 5, 2025
Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply
Timothy L Jackson, Helen Dakin, Xuemin Zhu, et al.
Personalized Medicine
|
September 4, 2023
Cost-effectiveness of extended <i>DPYD</i> testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone Huygens, et al.
Family Practice
|
June 22, 2006
Cluster randomized trial of a multifaceted primary care decision-support intervention for inherited breast cancer risk
Brenda J Wilson, Nicola Torrance, Jill Mollison, et al.
Genomic Medicine
|
October 17, 2008
Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom
Sarah Wordsworth, James Buchanan, Regina Regan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 13, 2022
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib
Simone Huygens, Heleen Vellekoop, Matthijs Versteegh, et al.
Applied Health Economics and Health Policy
|
April 4, 2022
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 2, 2023
Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
Chi Kin Law, Anne E Cust, Amelia K Smit, et al.
BMC Public Health
|
March 17, 2026
Social impact bonds: opportunities for funding health promotion and disease prevention
Stefánia Plankó, Emily Hulse, Maureen Rutten-van Mölken, et al.
Communications Medicine
|
May 25, 2024
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use
Laurence S J Roope, Liz Morrell, James Buchanan, et al.
Page
of 15